140 related articles for article (PubMed ID: 3533960)
1. Role of lipoproteins in growth of human adult arterial endothelial and smooth muscle cells in low lipoprotein-deficient serum.
Chen JK; Hoshi H; McClure DB; McKeehan WL
J Cell Physiol; 1986 Nov; 129(2):207-14. PubMed ID: 3533960
[TBL] [Abstract][Full Text] [Related]
2. Phosphatidyl choline and the growth in serum-free medium of vascular endothelial and smooth muscle cells, and corneal endothelial cells.
Fujii DK; Cheng J; Gospodarowicz D
J Cell Physiol; 1983 Mar; 114(3):267-78. PubMed ID: 6833402
[TBL] [Abstract][Full Text] [Related]
3. Lipoproteins increase growth of mitogen-stimulated arterial smooth muscle cells.
Libby P; Miao P; Ordovas JM; Schaefer EJ
J Cell Physiol; 1985 Jul; 124(1):1-8. PubMed ID: 3930513
[TBL] [Abstract][Full Text] [Related]
4. Lipoprotein(a) stimulates the proliferation of cultured human arterial smooth muscle cells through two pathways.
Miyata M; Biro S; Kaieda H; Tanaka H
FEBS Lett; 1995 Dec; 377(3):493-6. PubMed ID: 8549783
[TBL] [Abstract][Full Text] [Related]
5. Binding of platelet-derived growth factor and low density lipoproteins to glycosaminoglycan species produced by human arterial smooth muscle cells.
Fager G; Camejo G; Olsson U; Ostergren-Lundén G; Lustig F; Bondjers G
J Cell Physiol; 1995 May; 163(2):380-92. PubMed ID: 7706380
[TBL] [Abstract][Full Text] [Related]
6. Stimulation of arterial smooth muscle cell proliferation by remnant lipoprotein particles isolated by immuno-affinity chromatography with anti-apo A-I and anti-apo B-100.
Kawakami A; Tanaka A; Nakano T; Saniabadi A; Numano F
Horm Metab Res; 2001 Feb; 33(2):67-72. PubMed ID: 11294495
[TBL] [Abstract][Full Text] [Related]
7. Factors involved in the control of proliferation of bovine corneal endothelial cells maintained in serum-free medium.
Giguère L; Cheng J; Gospodarowicz D
J Cell Physiol; 1982 Jan; 110(1):72-80. PubMed ID: 6461663
[TBL] [Abstract][Full Text] [Related]
8. Metabolism of native and naturally occurring multiple modified low density lipoprotein in smooth muscle cells of human aortic intima.
Tertov VV; Orekhov AN
Exp Mol Pathol; 1997; 64(3):127-45. PubMed ID: 9439479
[TBL] [Abstract][Full Text] [Related]
9. Characteristics of low and high density lipoprotein binding and lipoprotein-induced signaling in quiescent human vascular smooth muscle cells.
Bochkov VN; Tkachuk VA; Kuzmenko YS; Borisova YL; Bühler FR; Resink TJ
Mol Pharmacol; 1994 Feb; 45(2):262-70. PubMed ID: 8114675
[TBL] [Abstract][Full Text] [Related]
10. Stimulation of the proliferation of the Madin-Darby canine kidney (MDCK) epithelial cell line by high-density lipoproteins and their induction of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity.
Gospodarowicz D; Cohen DC; Massoglia SL
J Cell Physiol; 1983 Oct; 117(1):76-90. PubMed ID: 6352714
[TBL] [Abstract][Full Text] [Related]
11. Effects of oxidized low density lipoprotein on the growth of human artery smooth muscle cells.
Zhao GF; Seng JJ; Zhang H; She MP
Chin Med J (Engl); 2005 Dec; 118(23):1973-8. PubMed ID: 16336833
[TBL] [Abstract][Full Text] [Related]
12. Effect of glycated low density lipoprotein on smooth muscle cell proliferation.
Makita T; Tanaka A; Numano F
Int Angiol; 1999 Dec; 18(4):331-4. PubMed ID: 10811523
[TBL] [Abstract][Full Text] [Related]
13. Cellular proliferation, cellular death and atherosclerosis.
Fischer-Dzoga K
Artery; 1979 Mar; 5(3):222-36. PubMed ID: 230798
[TBL] [Abstract][Full Text] [Related]
14. Oxidized low-density lipoprotein retards the growth of proliferating cells by inhibiting nuclear translocation of cell cycle proteins.
Zettler ME; Prociuk MA; Austria JA; Zhong G; Pierce GN
Arterioscler Thromb Vasc Biol; 2004 Apr; 24(4):727-32. PubMed ID: 14764420
[TBL] [Abstract][Full Text] [Related]
15. Oral contraceptive steroids and atherosclerosis: lipogenesis in human arterial smooth muscle cells and dermal fibroblasts in presence of lipoprotein-deficient serum from oral contraceptive users.
Subbaiah PV; Bagdade JD
Artery; 1980; 6(6):437-57. PubMed ID: 7436743
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of vascular smooth muscle cell proliferation and arterial intimal thickening by a novel antiproliferative naphthopyran.
Wiernicki TR; Bean JS; Dell C; Williams A; Wood D; Kauffman RF; Singh JP
J Pharmacol Exp Ther; 1996 Sep; 278(3):1452-9. PubMed ID: 8819533
[TBL] [Abstract][Full Text] [Related]
17. Remnant lipoprotein-induced smooth muscle cell proliferation involves epidermal growth factor receptor transactivation.
Kawakami A; Tanaka A; Chiba T; Nakajima K; Shimokado K; Yoshida M
Circulation; 2003 Nov; 108(21):2679-88. PubMed ID: 14623816
[TBL] [Abstract][Full Text] [Related]
18. Characteristics of smooth muscle cell lipoprotein binding proteins (p105/p130) as T-cadherin and regulation by positive and negative growth regulators.
Kuzmenko YS; Stambolsky D; Kern F; Bochkov VN; Tkachuk VA; Resink TJ
Biochem Biophys Res Commun; 1998 May; 246(2):489-94. PubMed ID: 9610389
[TBL] [Abstract][Full Text] [Related]
19. Human vascular smooth muscle cells in culture: growth characteristics and protein pattern by use of serum-free media supplements.
Dartsch PC; Weiss HD; Betz E
Eur J Cell Biol; 1990 Apr; 51(2):285-94. PubMed ID: 2190833
[TBL] [Abstract][Full Text] [Related]
20. Effects of insulin and glucose on the cells of the arterial wall: interaction of insulin with dibutyryl cyclic AMP and low density lipoprotein in arterial cells.
Young IR; Stout RW
Diabete Metab; 1987 Jul; 13(3 Pt 2):301-6. PubMed ID: 2820812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
